Cargando…
Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations
Respiratory Syncytial Virus (RSV) can cause severe respiratory disease, yet a licensed vaccine is not available. We determined the immunogenicity of two homologous and one heterologous intramuscular prime-boost vaccination regimens using replication-incompetent adenoviral vectors of human serotype 2...
Autores principales: | Salisch, N. C., Izquierdo Gil, A., Czapska-Casey, D. N., Vorthoren, L., Serroyen, J., Tolboom, J., Saeland, E., Schuitemaker, H., Zahn, R. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925274/ https://www.ncbi.nlm.nih.gov/pubmed/31885877 http://dx.doi.org/10.1038/s41541-019-0150-4 |
Ejemplares similares
-
Adenovector 26 encoded prefusion conformation stabilized RSV-F protein induces long-lasting Th1-biased immunity in neonatal mice
por: van der Fits, Leslie, et al.
Publicado: (2020) -
Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels
por: Tiemessen, Machteld M., et al.
Publicado: (2022) -
Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform
por: Salisch, Nadine C., et al.
Publicado: (2017) -
Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets
por: Khan, Selina, et al.
Publicado: (2022) -
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques
por: Roozendaal, Ramon, et al.
Publicado: (2021)